MetLife Investment Management, LLC
Position in AVIR — Atea Pharmaceuticals, Inc.
CIK 1529735
Whippany, NJ
Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$183,516
-$30,489 QoQ
Shares Held
39,466
-0.8% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 125 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. AVIR ranks #197 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,516 | 39,466 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $214,005 | 39,778 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $106,093 | 29,718 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $133,240 | 45,945 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $163,890 | 45,525 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $135,913 | 45,456 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $124,254 | 37,091 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $151,420 | 45,200 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $149,612 | 45,200 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $152,409 | 37,725 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $144,063 | 47,234 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $141,702 | 47,234 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $176,655 | 47,234 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $158,233 | 47,234 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $227,195 | 47,234 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $268,761 | 47,234 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $277,368 | 39,066 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $282,056 | 39,066 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $220,353 | 24,648 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $864,158 | 24,648 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $529,439 | 24,648 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $342,650 | 5,549 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $289,786 | 6,936 | Shares | Defined | 2024-05-24 | |
| No filing history on record for this holder in this stock. | ||||||